SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-315523
Filing Date
2017-10-20
Accepted
2017-10-20 17:20:03
Documents
4
Period of Report
2017-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d466476d8k.htm 8-K 16907
2 EX-5.1 d466476dex51.htm EX-5.1 8272
3 EX-10.1 d466476dex101.htm EX-10.1 56431
4 GRAPHIC g466476g15a09.jpg GRAPHIC 3366
  Complete submission text file 0001193125-17-315523.txt   87543
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 171147697
SIC: 2834 Pharmaceutical Preparations